Join the Neurogenic Bladder group to help and get support from people like you.
Neurogenic Bladder News
Robotic Cystectomy Approach Feasible for NLUTD and Interstitial Cystitis/Bladder Pain
MONDAY, July 21, 2025 – For adults with neurogenic lower urinary tract dysfunction (NLUTD) or interstitial cystitis/bladder pain syndrome (IC/BPS), robot-assisted laparoscopic supratrigonal...
Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS
WEDNESDAY, May 7, 2025 – For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS) are...
Ultrasound, 3D Printing Aid Sacral Neuromodulation for Neurogenic Bladder
FRIDAY, Jan. 3, 2025 – For patients with neurogenic bladder and pelvic structural anomalies, sacral neuromodulation (SNM) combined with three-dimensional (3D) printing and ultrasound localization...
Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
WEDNESDAY, Nov. 6, 2024 – Lower abdominal visceral fat area (VFA), older age, and prolonged surgery are independent risk factors for developing postoperative neurogenic bladder (PONB) after rectal...
Micronized Amnion/Chorion Aids Interstitial Cystitis/Bladder Pain Syndrome
THURSDAY, Oct. 31, 2024 – Injected micronized amnion/chorion bilayer (AC) product significantly reduces time to symptom relief in patients with refractory interstitial cystitis/bladder pain syndrome...
Botox (onabotulinumtoxinA) Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic Condition
NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ – Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved Botox® for the treatment of ...
FDA Approves VESIcare LS (solifenacin succinate) Oral Suspension for Neurogenic Detrusor Overactivity (NDO) Pediatric Patients
NORTHBROOK, Ill., May 27, 2020 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration (FDA)...